Last reviewed: June 4, 2026
Last updated: June 4, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Most patients starting semaglutide therapy wonder how many pens they'll need each month and whether their supply will change as treatment progresses. The answer depends on your personalized dosing schedule, which typically begins at a lower amount and increases gradually over weeks or months based on your body's response and tolerance. PlexusDx provides compounded semaglutide injections designed to support this gradual escalation without surprise cost increases.
How Semaglutide Dosing Schedules Affect Monthly Supply
Semaglutide treatment follows a structured escalation protocol rather than staying at one dose indefinitely. Most patients begin with a 0.25 mg weekly injection and increase by 0.25 mg every four weeks until reaching their optimal maintenance dose, typically between 1.0 mg and 2.4 mg weekly. This means your first month may require only one pen or vial, while your second and third months might use one pen per week as your dose climbs.
The total number of pens or vials needed monthly depends on whether you're in the dose escalation phase or maintaining a steady dose. During escalation weeks, you might use a 0.25 mg pen one week and a 0.5 mg pen the next week, depending on how your compounding pharmacy splits doses. Once you reach maintenance—typically after 16 to 20 weeks—you'll use the same pen or injection every seven days, creating a predictable monthly supply of exactly four injections.
Understanding Compounded Semaglutide Pens vs. Brand Alternatives
Compounded semaglutide from licensed 503A pharmacies offers the same active ingredient as brand-name Ozempic but is manufactured by pharmacies licensed to compound injectable medications under strict quality standards. PlexusDx sources all compounded semaglutide from licensed 503A compounding pharmacies, ensuring every dose meets pharmaceutical-grade specifications. Compounded versions allow for flexible dosing and personalized formulations that can be adjusted more easily than pre-filled pens locked into standard dose increments.
The practical advantage for monthly supply planning is flexibility. If your doctor recommends a 0.5 mg escalation instead of the standard 0.25 mg increment, a compounded pharmacy can prepare that exact dose without waste. Brand pens come in fixed strengths, which may not align with your doctor's preferred escalation schedule. This customization means you use exactly what you need each month rather than paying for supply that doesn't fit your protocol.
Calculating Your Monthly Semaglutide Needs During Dose Escalation
During the first month of therapy, most patients require only one 0.25 mg injection at the start of week one. Your second injection might come in week two, three, or four depending on whether you're following a weekly schedule or a staggered escalation. By week four, you'll receive your second dose increase. Throughout the escalation phase, your total monthly injections may range from two to four, depending on your specific protocol timeline and whether you're adjusting every week or every four weeks.
Once you reach a stable maintenance dose—for example, 2.0 mg weekly—you'll need exactly four injections per month. A simple calculation: maintenance dose × 4 weeks = total monthly units needed. At 2.0 mg weekly, that's 8 mg monthly. PlexusDx flat monthly pricing covers whatever dose you're on, whether you're in week one of escalation or maintaining a steady dose after three months. Your dose may need to go up, but your price stays the same.
PlexusDx Monthly Pricing Model for Semaglutide Therapy
PlexusDx offers compounded semaglutide injections starting at $149 per month across three commitment tiers, with pricing that remains flat regardless of your current dose level. Whether you're using one small injection monthly during initial titration or four full-strength injections by month four, your monthly cost does not increase. This transparent pricing model eliminates the anxiety many patients feel about whether stepping up to a higher dose will trigger a higher bill.
No insurance is required, and PlexusDx serves all 50 states with no membership fees. Patients can use HSA or FSA funds to cover compounded semaglutide, making treatment more accessible. When you're ready to know precisely how your genetic makeup influences your response to semaglutide, PlexusDx offers the Precision Peptide Genetic Test for $99 after your first month of treatment. This test evaluates key genetic variants affecting your GLP-1 receptor and metabolism, informing whether you might respond better to semaglutide alone or benefit from a dual-peptide approach.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
How many semaglutide injections will I actually use in my first month?
Most patients use one or two injections during their first month because dosing typically starts at 0.25 mg once weekly. By month two, you'll likely have two to three injections as your dose escalates. PlexusDx will discuss your specific schedule with your prescribing provider to ensure your supply matches your protocol exactly.
Does my monthly cost go up when my semaglutide dose increases?
No. PlexusDx charges a flat $149 per month (starting price across tiers) for compounded semaglutide injections, regardless of your current dose or whether you're escalating or maintaining. Your dose may need to go up, but your price won't.
What's the difference between compounded semaglutide and branded Ozempic pens?
Both contain the same active ingredient, but compounded semaglutide from licensed 503A pharmacies offers personalized dosing and flexible escalation schedules. Brand pens come in fixed strengths, while PlexusDx compounded versions can be tailored to your doctor's exact protocol, reducing waste and supporting your specific treatment plan.
Can I use my HSA or FSA to pay for compounded semaglutide from PlexusDx?
Yes. PlexusDx compounded semaglutide injections are HSA and FSA eligible, giving you tax-advantaged ways to cover treatment. No insurance is required, and PlexusDx serves patients in all 50 states with no membership fees.
How does the Precision Peptide Genetic Test help optimize my semaglutide supply needs?
PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month) analyzes your genetic variants in GLP1R, GIPR, FTO, and MC4R pathways.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Can You Take Ozempic 2 Times a Week? Understanding Dosing Strategies for Optimal Results
Does Tirzepatide Help with Cholesterol? Exploring the Impact on Lipid Profiles